When increased vaccine trust meets structural barriers to vaccine access

Trust in the COVID-19 vaccine has, by most measures, increased over the course of the rollout. But challenges can arise when newly-trusting potential recipients run up against issues getting access to the vaccine.
-------------
Clipped from the PRIM&R Webinar: The Colors of COVID-19: Embracing the Novel Ethical Challenges and Opportunities in COVID-19 Vaccine Trials.